North America Iliac Stent Market Size, Share & Trends Analysis Report By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By End-use, By Type, By Country and Growth Forecast, 2023 - 2030

The North America Iliac Stent Market would witness market growth of 5.3% CAGR during the forecast period (2023-2030).

The US market dominated the North America Others Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $38.7 million by 2030. The Canada market is experiencing a CAGR of 10.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.8% during (2023 - 2030).

Iliac stent procedures stand at the forefront of innovation, revolutionizing the treatment landscape for patients with the disease. The adoption trends in the market reflect a dynamic interplay of technological innovation, clinical evidence, regulatory considerations, and healthcare economics, shaping patterns of utilization and market dynamics.

Next-generation stent platforms offer improved radial strength, flexibility, and conformability, allowing for precise placement and optimal lesion coverage in challenging anatomies. Moreover, innovations in drug-eluting stents, bioresorbable stents, and surface-modified coatings aim to enhance patency rates, reduce restenosis, and improve long-term outcomes, driving the adoption of advanced stent technologies.

Canada has a high rate of vehicular accidents, which has raised demand for medical procedures such as the implantation of iliac stents to treat vascular problems and traumatic injuries. According to the Canadian government, in 2021, motor vehicle fatalities totalled 1,768, representing an increase of 1.3% compared to the 2020 figure of 1,746. Additionally, serious injuries from motor vehicle accidents rose by 4% to 8,185, while the total number of injuries increased by 3.6% to 1,08,018. Therefore, the increasing road traffic injuries and rapid urbanization in the region propel the market’s growth.

Free Valuable Insights: The Iliac Stent Market is Predict to reach USD 1.4 Billion by 2030, at a CAGR of 5.9%

Based on Artery Lesions, the market is segmented into Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. Based on End-use, the market is segmented into Hospitals, Outpatient Facilities, and Others. Based on Type, the market is segmented into Self-expandable Stents, Balloon-expandable Stents, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Becton, Dickinson and Company
• Abbott Laboratories
• Boston Scientific Corporation
• W.L. Gore & Associates, Inc.
• Medtronic PLC
• Cook Medical, Inc.(Cook Group)
• Terumo Corporation
• iVascular S.L.U.
• Getinge AB
• Biotronik SE & Co. KG

North America Iliac Stent Market Report Segmentation

By Artery Lesions

• Common Iliac Artery Lesions
• Severe Calcified Lesions
• Complete Obstructive Lesions

By End-use

• Hospitals
• Outpatient Facilities
• Others

By Type

• Self-expandable Stents
• Balloon-expandable Stents
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Iliac Stent Market, by Artery Lesions
1.4.2 North America Iliac Stent Market, by End-use
1.4.3 North America Iliac Stent Market, by Type
1.4.4 North America Iliac Stent Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. North America Iliac Stent Market by Artery Lesions
4.1 North America Common Iliac Artery Lesions Market by Country
4.2 North America Severe Calcified Lesions Market by Country
4.3 North America Complete Obstructive Lesions Market by Country

Chapter 5. North America Iliac Stent Market by End-use
5.1 North America Hospitals Market by Country
5.2 North America Outpatient Facilities Market by Country
5.3 North America Others Market by Country

Chapter 6. North America Iliac Stent Market by Type
6.1 North America Self-expandable Stents Market by Country
6.2 North America Balloon-expandable Stents Market by Country
6.3 North America Others Market by Country

Chapter 7. North America Iliac Stent Market by Country
7.1 US Iliac Stent Market
7.1.1 US Iliac Stent Market by Artery Lesions
7.1.2 US Iliac Stent Market by End-use
7.1.3 US Iliac Stent Market by Type
7.2 Canada Iliac Stent Market
7.2.1 Canada Iliac Stent Market by Artery Lesions
7.2.2 Canada Iliac Stent Market by End-use
7.2.3 Canada Iliac Stent Market by Type
7.3 Mexico Iliac Stent Market
7.3.1 Mexico Iliac Stent Market by Artery Lesions
7.3.2 Mexico Iliac Stent Market by End-use
7.3.3 Mexico Iliac Stent Market by Type
7.4 Rest of North America Iliac Stent Market
7.4.1 Rest of North America Iliac Stent Market by Artery Lesions
7.4.2 Rest of North America Iliac Stent Market by End-use
7.4.3 Rest of North America Iliac Stent Market by Type

Chapter 8. Company Profiles
8.1 Becton, Dickinson, and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Trials and Approvals:
8.1.6 SWOT Analysis
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Trials and Approvals:
8.3.6 SWOT Analysis
8.4 W. L. Gore & Associates, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 Medtronic PLC
8.5.1 Company overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Trials and Approvals:
8.5.6 SWOT Analysis
8.6 Cook Medical, Inc. (Cook Group)
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Terumo Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Trials and Approvals:
8.7.5.2 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 iVascular S.L.U.
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Getinge AB
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Trials and Approvals:
8.9.6 SWOT Analysis
8.10. Biotronik SE & Co. KG
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 North America Iliac Stent Market, 2019 - 2022, USD Million
TABLE 2 North America Iliac Stent Market, 2023 - 2030, USD Million
TABLE 3 North America Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
TABLE 4 North America Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
TABLE 5 North America Common Iliac Artery Lesions Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Common Iliac Artery Lesions Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Severe Calcified Lesions Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Severe Calcified Lesions Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Complete Obstructive Lesions Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Complete Obstructive Lesions Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Iliac Stent Market by End-use, 2019 - 2022, USD Million
TABLE 12 North America Iliac Stent Market by End-use, 2023 - 2030, USD Million
TABLE 13 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Outpatient Facilities Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Outpatient Facilities Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Iliac Stent Market by Type, 2019 - 2022, USD Million
TABLE 20 North America Iliac Stent Market by Type, 2023 - 2030, USD Million
TABLE 21 North America Self-expandable Stents Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Self-expandable Stents Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Balloon-expandable Stents Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Balloon-expandable Stents Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Iliac Stent Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Iliac Stent Market by Country, 2023 - 2030, USD Million
TABLE 29 US Iliac Stent Market, 2019 - 2022, USD Million
TABLE 30 US Iliac Stent Market, 2023 - 2030, USD Million
TABLE 31 US Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
TABLE 32 US Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
TABLE 33 US Iliac Stent Market by End-use, 2019 - 2022, USD Million
TABLE 34 US Iliac Stent Market by End-use, 2023 - 2030, USD Million
TABLE 35 US Iliac Stent Market by Type, 2019 - 2022, USD Million
TABLE 36 US Iliac Stent Market by Type, 2023 - 2030, USD Million
TABLE 37 Canada Iliac Stent Market, 2019 - 2022, USD Million
TABLE 38 Canada Iliac Stent Market, 2023 - 2030, USD Million
TABLE 39 Canada Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
TABLE 40 Canada Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
TABLE 41 Canada Iliac Stent Market by End-use, 2019 - 2022, USD Million
TABLE 42 Canada Iliac Stent Market by End-use, 2023 - 2030, USD Million
TABLE 43 Canada Iliac Stent Market by Type, 2019 - 2022, USD Million
TABLE 44 Canada Iliac Stent Market by Type, 2023 - 2030, USD Million
TABLE 45 Mexico Iliac Stent Market, 2019 - 2022, USD Million
TABLE 46 Mexico Iliac Stent Market, 2023 - 2030, USD Million
TABLE 47 Mexico Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
TABLE 48 Mexico Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
TABLE 49 Mexico Iliac Stent Market by End-use, 2019 - 2022, USD Million
TABLE 50 Mexico Iliac Stent Market by End-use, 2023 - 2030, USD Million
TABLE 51 Mexico Iliac Stent Market by Type, 2019 - 2022, USD Million
TABLE 52 Mexico Iliac Stent Market by Type, 2023 - 2030, USD Million
TABLE 53 Rest of North America Iliac Stent Market, 2019 - 2022, USD Million
TABLE 54 Rest of North America Iliac Stent Market, 2023 - 2030, USD Million
TABLE 55 Rest of North America Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
TABLE 56 Rest of North America Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
TABLE 57 Rest of North America Iliac Stent Market by End-use, 2019 - 2022, USD Million
TABLE 58 Rest of North America Iliac Stent Market by End-use, 2023 - 2030, USD Million
TABLE 59 Rest of North America Iliac Stent Market by Type, 2019 - 2022, USD Million
TABLE 60 Rest of North America Iliac Stent Market by Type, 2023 - 2030, USD Million
TABLE 61 Key Information – Becton, Dickinson and Company
TABLE 62 Key Information – Abbott Laboratories
TABLE 63 Key Information – Boston Scientific Corporation
TABLE 64 Key Information – W. L. Gore & Associates, Inc.
TABLE 65 Key Information – Medtronic PLC
TABLE 66 Key Information – Cook Medical, Inc.
TABLE 67 Key Information – Terumo Corporation
TABLE 68 Key Information – iVascular S.L.U.
TABLE 69 Key Information – Getinge AB
TABLE 70 Key Information – Biotronik SE & Co. KG

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Iliac Stent Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Iliac Stent Market
FIG 4 Porter’s Five Forces Analysis - Iliac Stent Market
FIG 5 North America Iliac Stent Market share by Artery Lesions, 2022
FIG 6 North America Iliac Stent Market share by Artery Lesions, 2030
FIG 7 North America Iliac Stent Market by Artery Lesions, 2019 - 2030, USD Million
FIG 8 North America Iliac Stent Market share by End-use, 2022
FIG 9 North America Iliac Stent Market share by End-use, 2030
FIG 10 North America Iliac Stent Market by End-use, 2019 - 2030, USD Million
FIG 11 North America Iliac Stent Market share by Type, 2022
FIG 12 North America Iliac Stent Market share by Type, 2030
FIG 13 North America Iliac Stent Market by Type, 2019 - 2030, USD Million
FIG 14 North America Iliac Stent Market share by Country, 2022
FIG 15 North America Iliac Stent Market share by Country, 2030
FIG 16 North America Iliac Stent Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Becton, Dickinson and company
FIG 18 SWOT Analysis: Abbott Laboratories
FIG 19 SWOT Analysis: Boston Scientific Corporation
FIG 20 SWOT Analysis: W. L. Gore & Associates, Inc.
FIG 21 SWOT Analysis: Medtronic PLC
FIG 22 SWOT Analysis: Cook Medical, Inc
FIG 23 SWOT Analysis: Terumo Corporation
FIG 24 SWOT Analysis: iVascular S.L.U.
FIG 25 SWOT Analysis: Getinge AB
FIG 26 SWOT Analysis: Biotronik SE & Co. KG